Crossmark

Comprehensive Benefit Evaluation and Clinical Decision-Making After 4-week Cinitapride Treatment on Functional Dyspepsia: A Multicenter, Prospective Designed, Real-World Study

Crossref DOI link: https://doi.org/10.1007/s10620-025-09585-9

Published Online: 2025-12-02

Published Print: 2026-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bai, Tao

Zhou, Dan

Chen, Jie

Zhu, Siran

Liu, Jinsong

Hou, Xiaohua
Clinical Trials ^BETA

Clinical trials referenced in this document:

chictr2100042166 at Chinese Clinical Trial Registry

Documents that mention this clinical trial

Comprehensive Benefit Evaluation and Clinical Decision-Making After 4-week Cinitapride Treatment on Functional Dyspepsia: A Multicenter, Prospective Designed, Real-World Study
https://doi.org/10.1007/s10620-025-09585-9
Funding

Funding for this research was provided by:

China Health Promotion Foundation
License Information

Text and Data Mining valid from 2025-12-02

Version of Record valid from 2025-12-02
More Information

Article History

Received: 12 December 2024

Accepted: 20 November 2025

First Online: 2 December 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below